SITC 2022: some thoughts in review
By Luka Ausec and Daniel Pointing Below are some observations, [...]
By Luka Ausec and Daniel Pointing Below are some observations, [...]
I/ML technology used to enhance drug development included in [...]
This study evaluates the efficacy of maintenance durvalumab in [...]
AI/ML technology helps therapeutic companies improve likelihood of clinical [...]
Welcome to Talking Precision Medicine — the podcast in [...]
The winners of Fast Company’s 2022 World Changing Ideas [...]
Renewed credentials underscore the computational precision medicine company’s commitment to [...]
Navicixizumab plus paclitaxel demonstrated promising clinical activity in bevacizumab-treated and -naive patients with platinum-resistant ovarian cancer, with manageable toxicity.
Cloud software for bioinformatics and systems biology is relaunched [...]
The Xerna™ TME Panel is a pan-cancer RNA-based investigational [...]